S&P 500 7,663.43 −1.21%
Nasdaq 26,008.86 −2.60%
S&P/TSX 35,973.45 −0.97%
Apple 348.22 +1.23%
Nvidia 212.21 −4.40%
Microsoft 521.08 −2.23%
Shopify 236.41 −3.48%
Royal Bank 282.78 −0.30%
CAD/USD 0.7141 +0.27%
AFTER HRS · 19:25 ET
Market ClerkRecap
Thu Oct 22 · after hours6 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead
CT
INSIDER · ARQT · Arcutis Biotherapeutics, Inc. · DIRECTOR

Curran Terrie

Every open-market transaction filed under this name, Aug 20 to Aug 27.

Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$984K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 27ARQTArcutis Biotherapeutics, Inc.DirectorSell27,052$25.03$677K+28.6%
Aug 27ARQTArcutis Biotherapeutics, Inc.DirectorSell11,148$25.03$279K+28.6%
Aug 20ARQTArcutis Biotherapeutics, Inc.DirectorSell1,072$26.04$28K+23.7%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.